Mina Thabet Gayed Kelleni
Department of Medicine
Minia University, Egypt
Dr. Kelleni obtained his MBBS degree with honor in 2004. He’s chosen a career in pharmacology after feeling frustrated from the lack of effective remedies for many diseases dedicating sincere efforts in his MSc research to explore a new remedy for NAFLD and in his PhD research to decrease the toxicity of antineoplastic drugs. He's struggling to raise pharmacovigilance in Egypt as well as to ban the toxic and carcinogenic drugs which are sorrowfully widely circulating in the Middle East. Dr. Kelleni is a member of the editorial boards of five international medical journals and he has received many invitations to participate as an honorable speaker in many well prestigious conferences in Greece, Spain, Taiwan, Dubai, USA, Canada, Morocco, Australia and China.
Lymphoma, Anti-neoplastic Drugs, Autoimmune disorders, Diabetes Mellitus, NAFLD, HCV Pharmacotherapy and Pharmacovigilance